Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,265 | 13,533 | 4,843 | 14,166 | 17,792 |
| Marketable Securities | 20,280 | 27,760 | 30,147 | 22,509 | N/A |
| Receivables | 2,000 | 3,146 | 5,262 | 8,876 | 4,700 |
| Inventories | 13,082 | 13,281 | 11,065 | 9,488 | 8,155 |
| Other current assets | 2,096 | 2,612 | 2,893 | 2,728 | 1,832 |
| TOTAL | $55,723 | $60,332 | $54,210 | $57,767 | $32,479 |
| Non-Current Assets | |||||
| PPE Net | 4,845 | 4,639 | 4,793 | 5,012 | 5,273 |
| Investments And Advances | 0 | 0 | 5,025 | 12,505 | 0 |
| Other Non-Current Assets | 7,366 | 7,339 | 7,682 | 7,592 | 7,640 |
| TOTAL | $12,211 | $11,978 | $17,500 | $25,109 | $12,913 |
| Total Assets | $67,934 | $72,310 | $71,710 | $82,876 | $45,392 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 21,147 | 21,698 | 18,617 | 23,187 | 18,400 |
| Other current liabilities | 5,394 | 16,720 | 18,352 | 19,014 | 16,335 |
| TOTAL | $86,474 | $43,895 | $42,415 | $47,628 | $40,175 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 8,497 | 61,730 | 64,059 | 66,129 | 75,539 |
| TOTAL | $8,497 | $61,730 | $64,059 | $66,129 | $75,539 |
| Total Liabilities | $94,971 | $105,625 | $106,474 | $113,757 | $115,714 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,383 | 33,337 | 32,443 | 32,443 | 14,838 |
| Common Shares | 35 | 33 | 33 | 33 | 15 |
| Retained earnings | -347,352 | -347,749 | -343,312 | -339,162 | -340,829 |
| TOTAL | $-27,037 | $-33,315 | $-34,764 | $-30,881 | $-70,322 |
| Total Liabilities And Equity | $67,934 | $72,310 | $71,710 | $82,876 | $45,392 |